logo
v4.0
登录 注册
商品名
活性成分
中文名称
申请类型
申请号
剂型
申请机构
批准日期
Alcohol
ANDA
219400
Solution;Intra-arterial
Xgen Pharms
2025-06-23
Alcohol
ANDA
217845
Solution;Intra-arterial
Accord Hlthcare
2025-06-23
Amitriptyline Hydrochloride
盐酸阿米替林
ANDA
218389
Tablet;Oral
Unique Pharm
2025-06-23
Dicyclomine Hydrochloride
盐酸双环维林
ANDA
219242
Capsule;Oral
Rising
2025-06-23
Alcohol
ANDA
219444
Solution;Intra-arterial
Breckenridge
2025-06-23
Datopotamab Deruxtecan-dlnk
BLA
761464
Injectable;Injection
Daiichi Sankyo Inc
2025-06-23
Apremilast
阿普米司特
ANDA
211834
Tablet;Oral
Torrent
2025-06-20
Lenacapavir
来那帕韦
NDA
220018
Tablet;Oral
Gilead Sciences Inc
2025-06-18
Lenacapavir
来那帕韦
NDA
220020
Tablet;Oral
Gilead Sciences Inc
2025-06-18
Acetazolamide Sodium
乙酰唑胺钠
ANDA
219775
Injectable;Injection
Gland
2025-06-17
Plerixafor
普乐沙福
ANDA
217560
Solution;Subcutaneous
Hetero Labs Ltd Vi
2025-06-16
Lisdexamfetamine Dimesylate
二甲磺酸赖右苯丙胺
BLA
219847
Solution;Oral
Azurity Pharmaceuticals Inc
2025-06-16
Garadacimab-gxii
BLA
761367
Injectable;Subcutaneous
Csl Behring Llc
2025-06-16
Safinamide Mesylate
甲磺酸沙非胺
ANDA
215913
Tablet;Oral
Zenara
2025-06-13
Carbidopa, Levodopa
ANDA
219231
Capsule, Extended Release
Dr Reddys Labs Ltd
2025-06-13
Clindamycin Phosphate
克林霉素磷酸酯
ANDA
219612
Solution;Topical
Carnegie
2025-06-13
Minocycline Hydrochloride
盐酸米诺环素
ANDA
214934
Injectable;Injection
Nexus
2025-06-12
Phentermine Hydrochloride; Topiramate
盐酸芬特明;托吡酯
ANDA
208175
Capsule, Extended Release;Oral
Dr Reddys Labs Sa
2025-06-12
Abacavir || Dolutegravir || Lamivudine
ANDA
210811
Tablet
Cipla Limited
2025-06-12
Sodium Iodide I-131
碘化钠I-131
ANDA
213615
Solution;Oral
Cardinal Hlth 414
2025-06-12
%s %s
共 27994 条 上一页 1 2345 10 下一页 到第 查看50页数据
客服热线
189-9650-1917
yyd@wuxuwang.com
美国上市药品数据库提供了在美国上市或曾经上市的全部药品的详细信息查询.
友情链接: